Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of $0.38, Misses by 4c
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reports Q3 loss of $0.38, versus the analyst estimate of ($0.34). Revenue for the quarter was $2.62 million, which compares to the estimate of $2.43 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
